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Objective: To determine which of two simplified blood glucose monitoring schemes promotes better metabolic
control in type1 diabetic patients during 12 months of participation in educational groups. Methods: A crossover
clinical trial involving 21 patients divided into two groups was conducted. They were submitted to a two monitoring
schemes:2 alternate daily preprandial measurements and 2 alternate daily pre-and postprandial measurements.
The effectiveness of the schemes was evaluated based on HbA1c. Variations in mean HbA1c were analyzed by
Friedman test. Results: The groups were homogenous in terms of sociodemographic and clinical variables
(p>0.05). Mean HbA1c levels ranged from 8.48 (±1.00) to 7.37 (±0.99) over time in Group A and from 9.89
(±0.86) to 8.34 (±1.06) in Group B. The analysis of the HbA1c showed a significant reduction in the first and
last 6 months and over the 12 months of the study in two groups (p<0.05). The preprandial scheme demonstrated
the largest number and highest percentage of significant drops in HbA1c. Conclusions: The two monitoring
improved the metabolic control and the preprandial scheme was more effective.
DESCRIPTORS: diabetes mellitus, type 1; blood glucose self-monitoring; nursing
MONITORIZACIÓN, EN EL DOMICILIO, DE LA GLUCEMIA EN PACIENTES CON
DIABETES MELLITUS TIPO 1
Objetivo: Identificar cual de los dos esquemas de monitorización propuestos posibilita realizar un mejor control
metabólico, en diabéticos del tipo1, durante los 12 meses de participación en grupos educativos. Método:
Ensayo clínico cruzado con 21 pacientes divididos en dos grupos y sometidos a dos diferentes esquemas de
monitorización. La efectividad de los esquemas fue evaluada por medio de la HbA1c. La variación de los
promedios de HbA1c fue analizada con la prueba de Friedman. Resultados: Durante todo el estudio la variación
de los promedios de HbA1c, para el grupo A, fue de 8,48(±1,00) la 7,37(±0,99) y de 9,89(±0,86) la 8,34(±1,06)
para el grupo B. Los análisis de la variación de la HbA1c colocaron en evidencia una reducción significativa
(p<0,05) en los dos grupos, en los 3 periodos evaluados: primeros y últimos 6 meses y durante los 12 meses
de estudio. Conclusiones: Los dos esquemas mejoraron el control metabólico y el esquema antes de las
comidas fue más efectivo.
DESCRIPTORES: diabetes mellitus tipo 1; automonitorización de la glucosa sanguínea; enfermería
MONITORIZAÇÃO DOMICILIAR DA GLICEMIA EM PACIENTES COM DIABETES
MELLITUS DO TIPO 1
Objetivo: Identificar qual de dois esquemas simplificados de monitorização da glicemia viabiliza melhor controle
metabólico, em pacientes com diabetes mellitus tipo 1, ao longo de 12 meses de participação em grupos
educativos. Método: Ensaio clínico cruzado, com 21 pacientes divididos em dois grupos. Eles foram submetidos
a dois esquemas de monitorização: duas medidas diárias pré-prandiais alternadas e duas medidas diárias pré
e pós-prandiais alternadas. A efetividade dos esquemas foi avaliada pelos níveis de HbA1c. Para estudar a
variação das médias das HbA1c aplicou-se o teste não paramétrico de Friedman. Resultados: Os grupos eram
homogêneos ao início do estudo com relação às variáveis sócio-demográficas e clinicas(p>0,05). A variação
das médias de HbA1c, ao longo do tempo para o grupo A foi de 8,48(±1,00) a 7,37(±0,99) e para o grupo B de
9,89(±0,86) a 8,34(±1,06). O resultado da análise da variação da HbA1c mostrou redução significativa nos
dois grupos, nos primeiros e últimos 6 meses e ao longo dos 12 meses nos dois grupos (p<0,05). O Esquema
de monitorizações pré-prandiais possibilitou o maior número e os maiores percentuais de quedas
estatisticamente significativas nos níveis de hemoglobina glicada. Conclusões: Os dois esquemas melhoraram
o controle metabólico e esquema pré-prandial foi mais efetivo.
DESCRITORES: diabetes mellitus tipo 1; automonitorizacão da glicemia; enfermagem
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One of the most significant studies to test the
proposal that complications of Type 1 Diabetes Mellitus
(DM1) are related to a chronic increase in blood glucose
was the Diabetes Control and Complications Trial
(DCCT)(1). The DCCT showed that intensive insulin
therapy to maintain glucose levels close to normal is
certainly effective in minimizing the development and
progression of complications of DM(1).
Many questions have been raised regarding the
difficulties in implementing the rigid controls
recommended by the DCCT and also regarding their
implications in clinical practice, educational programs,
self-monitoring, quality of life and treatment costs,
especially at services where no resources or trained
professionals are available. Alternative strategies for
the control of DM that take into account individual
limitations and deficits in the health system related to
human and financial resources are necessary and are
the main objective of the present study. The objective
of the present study was to evaluate the effectiveness
of two different home blood glucose monitoring schemes
in improving glucose control in patients with DM1
undergoing a monthly therapeutic adjustment regimen
over a period of 12 months of participation in educational
groups.
PATIENTS AND METHODS
This randomized crossover study was carried
out at the outpatient clinic of the “League of Diabetes”,
Discipline of Endocrinology, HC-FMUSP. The study
population consisted of subjects with DM1 enrolled in
the service who complied with the following inclusion
criteria: age older than 2 years, motivation to monitor
blood glucose twice a day for a period of 12 months,
and the basic socioeconomic-cultural and cognitive
conditions necessary to attend the educational groups
and to participate in the activities developed. Excluded
were patients with less than 2 years of the disease,
patients sporadically or continuously using
hyperglycemic drugs, patients with other DM-associated
endocrinopathies, and subjects who did not agree to
participate in the study. The sample consisted of 21
patients who already monitored blood glucose levels
once a day and who fulfilled the criteria described above.
The patients were then randomly divided into
two groups by drawing lots. Group A used Scheme 1
for monitoring blood glucose during the first 6 months
of the study and Scheme 2 during the subsequent 6
months. Group B used Scheme 2 during the first 6
months of the study and Scheme 1 during the subsequent
6 months. In Scheme 1, the patients self-monitored
capillary blood glucose levels twice a day at preprandial
times (30 min before meals), at bedtime and at 3 am
every 2 weeks over a period of 6 months. In Scheme
2, the patients self-monitored capillary blood glucose
levels twice a day at preprandial (30 min before meals)
and postprandial times (90 to 120 min after meals) and
at 3 am every 2 weeks over a period of 6 months. The
effectiveness of the monitoring schemes in promoting
metabolic control was evaluated by the measurement
of glycated hemoglobin (HbA1c) concentration and the
results obtained during 12 months were compared to
baseline values (November 2003). The patients and their
caregivers participated in monthly educational group
meetings with the multi-professional team. The meetings
of groups A and B were held on different days. The
insulin regimens used consisted of 2 to 4 daily
applications (before breakfast, before lunch, before
dinner, and at bedtime) of intermediate-acting (NPH)
and ultrarapid-acting insulin (Lispro). Lispro insulin was
applied 15 min before meals. In order to create
objective criteria for the therapeutic adjustment of
insulin, one week of intensive monitoring consisting of
8 daily pre- and postprandial measurements (run in)
was performed at the beginning of the study to determine
factors indicating insulin sensitivity and to calculate
correction factors to be applied during the study when
the number of glucose tests was reduced to twice a
day. The same scheme was repeated at the time of
inversion of the groups as wash-out. The project was
approved by the Ethics Committee of HC-FMUSP
(process No.521/01).
The data of this study were collected using
seven different instruments containing data regarding
identification, socio-demographic and clinical variables,
insulin treatment regimen and adjustments, capillary
blood glucose levels, daily problems, glucose profile,
anthropometric measurements, and dietary record.
Blood was collected from patients of groups A
and B for the measurement of HbA1c (HPLC, normal
range: 4.1 to 6.5%) before (baseline values) and 2, 4,
6, 8, 10 and 12 months after the beginning of the study.
As a control parameter, all patients had their HbA1c
levels compared to baseline values. The patients were
instructed regarding the correct technique for capillary
blood glucose testing. Finger punctures were performed
with Soft Touch Lancets and Advantage System strips
were used for glucose testing (both from Boehringer
Mannheim Corporation). The quality of the glucose
measurements was determined according to the
recommendations of the American Diabetes
Association(2).
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The data were analyzed under the supervision
of a statistician, using SPSS for Windows, version 10.0.
Results presenting a p value < 0.05 were considered
significant. The following tests were applied to determine
the homogeneity of the groups at the beginning of the
study: nonparametric Mann-Whitney test for HbA1c,
family income, household members, Student t-test for
age and BMI, and Fisher’s test for gender, educational
level and housing conditions. Along the study, all other
analyses consisted of the interpretation of intragroup
data. The nonparametric Friedman test was applied to
study the variation in HbA1c and mean glucose levels
between the different periods and over time. These
analyses were performed separately for each group
during the course of the two schemes. When a significant
difference in HbA1c concentration was detected,
Bonferroni multiple comparisons were performed to
identify between which two months the difference
occurred. The Wilcoxon test was used for intragroup
comparisons of two schemes.
RESULTS
The characteristics of groups A and B are shown
in Table 1.
Table 1 - Characteristics of groups A and B
scitsiretcarahC
)12=n( ApuorG BpuorG eulav-p
scitsiretcarahC
)12=n( ApuorG BpuorG eulav-p
sraeyniegA $RniemocniylimaF
)DS(naeM )91.3(28.11 )8.2(04.9 *280.0 )DS(naeM )80.215(00.0021 )12.379(00.5701
redneG naideM 00.0011 00.005
elaM )%4.63(4 )%0.03(3 egnaR 0002-005 0092-053 ***122.0
elameF )%6.36(7 )%0.07(7 **999.0 srebmemdlohesuohfo.oN
levellanoitacudE )DS(naeM )36.0(08.3 )75.1(41.4
loohcsyramirpetelpmocnI )%0.05(5 )%0.001(7 naideM 00.4 00.4
loohcsyramirpetelpmoC )%0.01(1 egnaR 5-3 6-2 ***917.0
loohcselddimetelpmocnI )%0.02(2 c1AbHenilesaB
loohcselddimetelpmoC )%0.02(2 **332.0 )DS(naeM )62.1(15.8 )38.1(29.8 ***845.0
gnillewdehtnismoorfo.oN snoitacilpmoccinorhC
naeM 01.4 00.4 seY
naideM 00.4 00.5 oN )%00.001(11 )00.001(01
egnaR 01.1 36.1 **029.0 IMB
)DS(naeM )29.3(97.91 )08.1(85.71
egnaR 7.62-3.51 4.12-5.51 *921.0
SD: standard deviation; BMI: body mass index; * Student t-test; ** Fisher’s exact test; *** Mann-Whitney test.
The Mann-Whitney test confirmed the
homogeneity of the sample in terms of HbA1c levels
at baseline (p=0.548).These values were used as a
control parameter for the subsequent analyses. With
respect to the glycemic profiles, mean pre- and
postprandial glycemic levels and glycemic variation
were higher than desired in the two groups over time
and no significant difference was observed over time
in either group or between periods (nonparametric
Friedman test, p>0.05).
#baseline; *scheme 1; **scheme2; Friedman test: p<0.001
Table 2. Variation in HbA1c concentration over time
in group A
The lowest mean was obtained during the
last measurement in Scheme 1 and the poorest mean
was observed when the patients changed to Scheme
2. The nonparametric Friedman test showed a
significant decrease of mean HbA1c levels in group
A over time.
Table 3. Variation in HbA1c concentration over time
in group B
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#baseline; *scheme 2; ** scheme1; Friedman test: p=0.002
A significant decline in mean HbA1c levels
over time was also observed in group B.
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40tpeS/c1AbH **74.7 13.1 53.6 04.7 55.8 9
40voN/c1AbH **65.7 28. 00.7 04.7 02.8 9
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Analysis of the variation in HbA1c
concentration over time by the Friedman test showed
a significant difference in the first (p=0.0004) and
last 6 months (p=0.002) and along the 12 months
(p<0.001) of the study in group A, and a significant
difference in the first (p=0.028) and last 6 months
(p=0.006) and along the 12 months (p=0.002) of the
study in group B, irrespective of the current scheme.
Tables 4 and 5 show basal, intra-and
interscheme comparisons of mean HbA1c
concentration between the different months over the
12 months of the study. Comparisons of basal/Scheme
1 and intrascheme 1 showed that this scheme
promoted three nonsignificant increases of HbA1c
levels in groups A and B and nine declines, four of
them being significant. The same comparison for
Scheme 2 also showed three nonsignificant increases
and nine declines, one of them significant. Interscheme
comparisons revealed six increases, two of them
significant and three declines, one of them significant
when changing from Scheme 1 to Scheme 2 (Table
4).When changing from Scheme 2 to Scheme 1, the
comparisons showed seven declines, two of them
significant, and two nonsignificant increases (Table
5). Schemes 1 and 2 were compared within each group
by the nonparametric Wilcoxon test for paired
samples. The results showed no significant difference
in mean HbA1c levels between schemes in group A
(p=0.79), whereas in group B Scheme 1 significantly
improved glycemic levels (p=0.021).
Table 4. Multiple comparisons of mean HbA1c in group A
* Statistically significant; ** Change from Scheme 1 to Scheme 2
Table 5. Multiple comparisons of mean HbA1c in group B
* Statistically significant; ** Change from Scheme 2 to Scheme 1
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Although analysis of glycemic profiles did not
reveal significant improvement, metabolic control
improved in the two groups studied irrespective of
the scheme used. Although mean glycated hemoglobin
concentration remained above the upper limit of the
method, which is 6.5%, disagreeing with the patterns
recommended in the literature, which classifies values
of up to 10% above the upper limit of the method as
satisfactory(1), analysis of HbA1c variation showed a
significant reduction in the first and last 6 months and
along the 12 months of the study in the two groups. It
is possible that the therapeutic adjustments the team
performed monthly based on individual glycemic
profiles improved glycemic levels at times not
contemplated in the schemes proposed, an
improvement reflected in HbA1c levels. The fact that
this improvement occurred irrespective of the scheme
used suggests that the two monitoring strategies
contributed to this improvement. As demonstrated in
other studies, these results confirm that, when a
monitoring program is encouraged(3-5) or when
glycemic values are used to understand the interaction
between insulin therapy, diet, physical activity and
complications and to guide treatment, blood glucose
monitoring effectively improves metabolic control and
treatment compliance increases both among young
patients and among those above the age of 60(5-7).
It has been well documented in the literature
that, the larger the number of glucose tests performed,
the greater the opportunities for insulin adjustment
and the better the glycemic control(3,7-9). In a study
evaluating the effect of an insulin therapy regimen
on metabolic control in 229 children, it was
demonstrated that an increase in the frequency of
blood glucose monitoring (1 to 6 times per day) was
correlated with lower HbA1c (r=-0.15, p=0.006), with
each additional daily monitoring resulting in a 0.4%
decrease in HbA1c concentration, and that the number
of insulin types and applications was correlated with
increased HbA1c (r=0.2, p=0.02), with each additional
insulin dose resulting in a 0.46% increase in HbA1c
concentration(10). Other studies have also
demonstrated a correlation between lower HbA1c and
the frequency of daily tests for blood glucose
monitoring(8-12). Some studies found no association
between the frequency of blood glucose monitoring
and better metabolic control(4,13).In a population study,
data on the frequency of daily monitoring were
obtained by questionnaires and the aim of that study
was not to use blood glucose testing as a therapeutic
strategy but only to investigate its relationship with
HbA1c concentration(13). Another study was conducted
on 60 patients with DM1 who participated in an
encouraged long-term self-monitoring program. High
compliance with the program was observed during
the first 6 months, with a frequency of about four
daily monitorings, but only 50% of the subjects
continued in the program for more than 3 years.
During a critical period of the study, comprising the
8th to 11th semester, a higher frequency of daily
monitoring was correlated with glycemic levels higher
than 180 mg/dl and poor HbA1c values(4).The authors
concluded that the worsening of metabolic control
demonstrated by the increased HbA1c and capillary
glucose tends to increase the frequency of monitoring.
We agree with this conclusion.
When no intensive or ideal glucose monitoring
is possible, which is the case for most health services
in developing countries, alternative and less expensive
strategies for blood glucose monitoring such as that
proposed here can be adopted. Although not ideal, the
present proposal permitted to improve the condition
of the participants, with two daily glucose tests.
Improvement of metabolic control with two daily
monitorings on average has also been documented in
a long-term follow-up study after the 12th semester
and after a period of deterioration of glycemic control,
when the participants readjusted to the requirements
of the program(4).We found no studies in the literature
reporting glycemic profiles obtained with the application
of simplified monitoring strategies in patients with DM1.
Many of the investigations mention such strategies but
the study is focused on other variables. An interesting
study evaluating glycemic profiles was conducted on
150 patients with stable type 2 diabetes in order to
determine the effectiveness of once- and twice-daily
self-monitored blood glucose testing strategies in
detecting hyperglycemia and hypoglycemia. The pre-
breakfast and pre-lunch measurements detected the
largest proportion (63.6%) of hypoglycemic readings,
pre-dinner and bedtime measurements detected the
largest proportion (66.2%) of hyperglycemic readings,
and pre-lunch and pre-dinner measurements detected
the largest proportion (57.7%) of all hypoglycemic and
hyperglycemic readings(14).These data support our
intention to continue investigating and adopting
simplified monitoring strategies in low-income
populations.
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Deterioration of metabolic control was
observed in the two groups when changing from one
scheme to the other (July), a finding indicating an
adaptive phase during the new scheme. We believe
that blood glucose monitoring consisting of two daily
tests was not the only factor responsible for the
improved metabolic control of the participants in this
study. Monthly participation in the educational group,
individual nutritional care and the bond established
with the team surely contributed to this finding, since
significant reductions in glycated hemoglobin were
already observed at the end of the first 6 months
(May) in the two groups and during the last 6 months
of the two schemes (November).
The importance of education and
comprehensive therapeutic support of patients with
chronic diseases has been reported in some
studies(13,15-16).The requirements for self-care and the
psychosocial aspects involved in the daily
management of diabetes are a source of stress, which
might be minimized by personal engagement in the
development of knowledge and adequate behaviors
to cope with these situations(17).The role of the
healthcare team in training and education programs
is to adopt strategies to improve the way diabetic
patients cope with daily situations and
complications(17).In this respect, there was constant
concern on the part of the professionals involved in
the educational groups and individual meetings to
enable and provide specific support to the participants
in order to make decisions regarding diet, exercise,
insulin adjustment, and management of hypoglycemia
and other complications. The patients and their
relatives were encouraged to understand the glycemic
profiles and to discuss procedures with the team and
could freely express their opinion and difficulties.
Submissive behaviors were discouraged. The bond
established between patients, relatives and the team
was maintained throughout the 12 months, including
telephone contact. We believe that the knowledge
acquired and the approach established in educational
practice substantially contributed to the improved
metabolic control observed in the two groups.
The importance of this type of understanding
approach objectively directed at solving daily
problems related to the lack of glycemic control has
been well described in a study involving 842 diabetic
adults treated with insulin. The authors emphasized
that blood glucose monitoring is not sufficient but that
the patients should be able to manage the lack of
glycemic control with the help of the team, which plays
a fundamental role in the teaching and correction of
judgment errors related to disease management(6).
The findings of an American multicenter study
including 3567 adult patients with type 2 diabetes
suggest that home blood glucose self-monitoring plays
an important role in metabolic control only if it is an
integral part of educational strategies aimed at
promoting patient autonomy(13). Although the present
study involved children and adolescents, we believe
that favoring autonomy is a fundamental aspect of
treatment compliance in chronic diseases, especially
in adolescents.
In order to better understand the behavior
of the groups regarding the two different monitoring
strategies proposed here, multiple comparisons of
mean HbA1c concentration were performed between
the different months (Tables 4 and 5). Basal and
intrascheme comparisons demonstrated a superiority
of Scheme 1 in terms of improving metabolic control
in the two groups, since four statistically significant
declines were observed during the course of this
scheme versus only one significant decline during
Scheme 2. The greater effectiveness of Scheme 1
was demonstrated by the significant reduction of
glycated hemoglobin levels in group B (Table 5).
Interscheme comparisons revealed worsening of
metabolic control when changing from Scheme 1 to
Scheme 2, with six increases in HbA1c, two of them
significant (Table 4).When changing from Scheme 2
to Scheme 1, HbA1c levels improved as confirmed
by the observation of seven declines, two of them
significant (Table 5).The higher effectiveness of
Scheme 1 can also be demonstrated when comparing
the percentage reduction in HbA1c concentration
between the beginning and end of the schemes.
During Scheme 1, a 0.83% reduction was observed
in group A during the first 6 months and a 0.30%
reduction was noted in group B during the last 6
months. During Scheme 2, HbA1c concentration
declined by 0.12% in group B during the first 6 months
and increased by 0.19% in group A during the last 6
months. Since, during Scheme 1, the patients only
adjusted preprandial insulin doses, the possibility of
adjustments was greater, a fact that certainly
contributed to the higher effectiveness of this strategy.
Thus, in the present study, in which preprandial
adjustment was used, it is possible to affirm that
Scheme 1 was more effective than Scheme 2 in
promoting metabolic control.
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The two monitoring schemes permitted
therapeutic adjustments that promoted significant
improvement of metabolic control in the two groups
as measured by HbA1c levels. This improvement
seems to be related to an increased number of
opportunities for therapeutic adjustment provided by
the monthly meetings, monitoring and the educational
program developed. Scheme 1 consisting of
preprandial monitoring of blood glucose associated
with the adjustment of insulin doses before meals was
more effective in promoting metabolic control since it
permitted a larger number of significant declines in
HbA1c.The percentage of these declines was also
higher during this scheme. Group A presented less
variability and better HbA1c indices throughout the
study, but there was no statistical explanation for the
better performance of this group. It is possible that
some intrinsic characteristics of this group not
evaluated in the present study influenced the results,
such as greater interest, compliance and participation.
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